Addressing barriers to vaccine acceptance: an overview

Human Vaccines and Immunotherapeutics

Volumn 14, Issue 1, 2018, Pages 218-224

  MacDonald, Noni E ^a   Butler, Robb ^b   Dubé, Eve ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

immunization; vaccine acceptance; vaccine communication; vaccine hesitancy; vaccine strategies

Indexed keywords

INFLUENZA VACCINE; VACCINE;

ARTICLE; DECISION MAKING; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HUMAN; IMMUNIZATION; INTERPERSONAL COMMUNICATION; PAIN; ATTITUDE TO HEALTH; EVIDENCE BASED PRACTICE; PATIENT ATTITUDE; PATIENT EDUCATION; PREVENTIVE HEALTH SERVICE; PROFESSIONAL-PATIENT RELATIONSHIP; PSYCHOLOGY; VACCINATION; VACCINATION REFUSAL;

DECISION MAKING; EVIDENCE-BASED PRACTICE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; IMMUNIZATION PROGRAMS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PROFESSIONAL-PATIENT RELATIONS; VACCINATION; VACCINATION REFUSAL;

EID: 85035354783     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2017.1394533     Document Type: Article

References (71)

1. World Health Organization Global Vaccine Action Plan 2011–2020. 2014. Available at: www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/ (accessed Jan2017).
2. World Health Organization. Report of the SAGE Working Group on Vaccine Hesitancy. 2014. Available at: http://www.who.int/immunization/sage/meetings/2014/october/SAGE_working_group_revised_report_vaccine_hesitancy.pdf?ua=1(accessed Jan2017).
3. Marti M, de Cola M, MacDonald NE, Dumolard L, Duclos P. Assessments of global drivers of vaccine hesitancy in 2014: looking beyond vaccine safety concerns. Submitted, under second review.
4. MacDonald NE, and SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33:4161–4. doi:10.1016/j.vaccine.2015.04.036.
5. Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy. An overview. Human Vaccines & Immunotherapeutics. 2013;9:1763–73.
6. Jarrett C, Wilson R, O'Leary M, Eckersberger E, Larson HJ and the SAGE Working Group on Vaccine Hesitancy Strategies for addressing vaccine hesitancy -a systematic review. Vaccine. 2015;33:4180–90. doi:10.1016/j.vaccine.2015.04.040.
7. Dubé E, Gagnon D, MacDonald NE, and the SAGE Working Group on Vaccine Hesitancy. Strategies intended to address vaccine hesitancy: Review of published reviews. Vaccine. 2015;33:4191–203. doi:10.1016/j.vaccine.2015.04.041.
8. Smith JC, Appleton M, MacDonald NE. Building confidence in vaccines. Adv Exp Med Biol. 2013;764:81–98.
9. Kahan DM., A risky science communication environment for vaccines. Science. 2013;342:53–4. doi:10.1126/science.1245724.
10. Bauch CT, Galvani AP. Social factors in epidemiology. Science. 2013;342:47–9. doi:10.1126/science.1244492. PMID:24114781
11. Betsch C, Renkewitz F, Betsch T, Ulshöfer C. The influence of vaccine critical websites on perceiving vaccination risks. J Health Psychol. 2001;15:446–55. doi:10.1177/1359105309353647.
12. Betsch C, Brewer NT, Brocard P, Davies P, Gaissmaier W, Haase N, Leask J, Renkewitz F, Renner B, Reyna VF, et al. Opportunities and challenges of Web 2.0 for vaccination decisions. Vaccine. 2012;30:3727–33. doi:10.1016/j.vaccine.2012.02.025.
13. Nan X, Madden K. HPV Vaccine information in the blogosphere: how positive and negative blogs influence vaccine-related risk perceptions, attitudes, and behavioral intentions. Health Communication. 2012;27:829–36. doi:10.1080/10410236.2012.661348.
14. Dunn AG, Leask J, Zhou X, Mandl KD, Coiera E. Aassociations between exposure to and expression of negative opinions about human papillomavirus vaccines on social media: an observational study. J Med Internet Res. 2015;17:e144. doi:10.2196/jmir.4343. PMID:26063290
15. Guidry JPD, Carlyle K, Messner M, Jin Y. On pins and needles: How vaccines are portrayed on Pinterest. Vaccine. 2015;33:5051–6. doi:10.1016/j.vaccine.2015.08.064.
16. Stahl JP, Cohen R, Denis F, Gaudelus J, Martinot A, Lery T, Lepetit H. The impact of the web and social networks on vaccination. New challenges and opportunities offered to fight against vaccine hesitancy. Med Mal Infect. 2016;46:117–22. doi:10.1016/j.medmal.2016.02.002.
17. Goldstein S, MacDonald NE, Guirguis S, and the SAGE Working Group on Vaccine. Health communication and vaccine hesitancy. Vaccine. 2015;33:4212–14. doi:10.1016/j.vaccine.2015.04.042.
18. Nyhan B, Reifler J, Richey S, Freed GL. Effective messages in vaccine promotion: a randomized trial. Pediatrics. 2014;133:e835−42. doi:10.1542/peds.2013-2365.
19. Thomson A, Robinson K, Vallée-Tourangeau G. The 5As: A practical taxonomy for the determinants of vaccine uptake. Vaccine. 2016; 34:1018–24. doi:10.1016/j.vaccine.2015.11.065.
20. Witteman HO., Addressing vaccine hesitancy with values. Pediatrics. 2015;136:215–7. doi:10.1542/peds.2015-0949.
21. World Health Organization Regional Office of Europe. TIP Implementation in the UK. Available at: http://www.euro.who.int/en/health-topics/communicable-diseases/measles-and-rubella/activities/tailoring-immunization-programmes-to-reach-underserved-groups-the-tip-approach/tip-country-projects/tip-implementation-in-the-united-kingdom (accessed Jan2017).
22. Sabbe M, Hue D, Hutse V, Goubau P. Measles resurgence in Belgium from January to mid-April 2011: a preliminary report. Euro Surveill. 2011;16. pii = 19848. Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19848 (accessed Jan2017).
23. Butler R, MacDonald NE, and the SAGE Working Group on Vaccine Hesitancy. Diagnosing the determinants of vaccine hesitancy in specific subgroups: The Guide to Tailoring Immunization Programmes (TIP). Vaccine. 2015;33:4176–9. doi:10.1016/j.vaccine.2015.04.038.
24. World Health Organization Regional Office in Europe 2013. Tailoring immunization programmes to reach underserved groups–the TIP approach. Available at: http://www.euro.who.int/en/health-topics/communicable-diseases/measles-and-rubella/activities/tailoring-immunization-programmes-to-reach-underserved-groups-the-tip-approach/the-tip-guide-and-related-publication. (accessed Jan2017)
25. Zhang J, While AE, Norman IJ. Knowledge and attitudes regarding influenza vaccination among nurses: a research review. Vaccine. 2010;28:7207–14. doi:10.1016/j.vaccine.2010.08.065.
26. Collange F, Verger P, Launay O, Pulcini C. Knowledge, attitudes, beliefs and behaviors of general practitioners/family physicians toward their own vaccination: A systematic review. Hum Vaccin Immunother. 2016;12:1282–92. doi:10.1080/21645515.2015.1138024.
27. Favin M, Steinglass R, Fields R, Banerjee K, Sawhney M. Why children are not vaccinated: a review of the grey literature. Int Health. 2012;4:229–38. doi:10.1016/j.inhe.2012.07.004.
28. Shibli R, Shemer R, Lerner-Geva L, Rishpon S. Knowledge and recommendation regarding routine childhood vaccinations among pediatric healthcare providers in Israel. Vaccine. 2017;35(4):633–38. pii:S0264-410X(16)31199-9.
29. United Nations Children's Fund (UNICEF). Building trust in immunization. Partnering with religious leaders and groups. UNICEF. 2004. Available at: https://www.unicef.org/ceecis/building_trust_immunization.pdf. (accessed Jan2017)
30. Grabenstein JD., What the world's religions teach, applied to vaccines and immune globulins. Vaccine. 2013;31:2011–23. doi:10.1016/j.vaccine.2013.02.026.
31. Kaliner E, Moran-Gilad J, Grotto I, Somekh E, Kopel E, Gdalevich M, Shimron E, Amikam Y, Leventhal A, Lev B, Gamzu R. Silent reintroduction of wild-type poliovirus to Israel, 2013–risk communication challenges in an argumentative atmosphere.Euro Surveill. 2014;19:20703.
32. Szilagyi PG, Schaffer S, Rand CM, Vincelli P, Eagan A, Goldstein NP, Hightower AD, Younge M, Blumkin A, Albertin CS, et al. School-Located Influenza Vaccinations: A Randomized Trial. Pediatrics. 2016;138:pii:e20161746. doi:10.1542/peds.2016-1746.
33. Public Health England. Childhood Influenza Vaccination Pilot Programme, England 2014/15. End of season report Covering flu vaccinations administered as part of the school-age pilot programme from 1 September 2014 to 31 January 2015. 2016. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/522839/Chidhood_Flu_Vaccination_Pilot_Pogramme_England_201415_End_of_Season_Report_Final.pdf. (accessed Jan2017)
34. Harvey H, Reissland N, Mason J. Parental reminder, recall and educational interventions to improve early childhood immunisation uptake: A systematic review and meta-analysis. Vaccine. 2015;33:2862–80. doi:10.1016/j.vaccine.2015.04.085.
35. Domek GJ, Contreras-Roldan IL, O'Leary ST, Bull S, Furniss A, Kempe A, Asturias EJ. SMS text message reminders to improve infant vaccination coverage in Guatemala: A pilot randomized controlled trial. Vaccine. 2016;34:2437–43. doi:10.1016/j.vaccine.2016.03.065.
36. Salmon DA, MacIntyre CR, Omer SB. Making mandatory vaccination truly compulsory: well intentioned but ill conceived.Lancet Infect Dis. 2015;15:872–3.
37. Salmon DA, Teret SP, MacIntyre CR, Salisbury D, Burgess MA, Halsey NA. Compulsory vaccination and conscientious or philosophical exemptions: past, present, and future. Lancet. 2006;367:436–42. doi:10.1016/S0140-6736(06)68144-0.
38. Moss JL, Reiter PL, Truong YK, Rimer BK, Brewer NT. School Entry Requirements and Coverage of Nontargeted Adolescent Vaccines. Pediatrics. 2016;138:e20161414. doi:10.1542/peds.2016-1414. PMID:27940689
39. Dubov A, Phung C. Nudges or mandates? The ethics of mandatory flu vaccination. Vaccine. 2015;33:2530–5. doi:10.1016/j.vaccine.2015.03.048.
40. Fu LY, Zook K, Gingold JA, Gillespie CW, Briccetti C, Cora-Bramble D, Joseph JG, Haimowitz R, Moon RY. Strategies for Improving Vaccine Delivery: A Cluster-Randomized Trial. Pediatrics. 2016;137(6):pii:e20154603. doi:10.1542/peds.2015-4603.
41. Wigham S, Ternent L, Bryant A, Robalino S, Sniehotta FF, Adams J. Parental financial incentives for increasing preschool vaccination uptake: systematic review. Pediatrics. 2014;134:e1117−28. doi:10.1542/peds.2014-1279.
42. Shelby A, Ernst K. Story and science: how providers and parents can utilize storytelling to combat anti-vaccine misinformation. Hum Vaccin Immunother. 2013;9:1795–801. doi:10.4161/hv.24828.
43. Odone A, Ferrari A, Spagnoli F, Visciarelli S, Shefer A, Pasquarella C, Signorelli C. Effectiveness of interventions that apply new media to improve vaccine uptake and vaccine coverage. Hum Vaccin Immunother. 2015;11:72–82. doi:10.4161/hv.34313.
44. Scherer LD, Shaffer VA, Patel N, Zikmund-Fisher BJ. Can the vaccine adverse event reporting system be used to increase vaccine acceptance and trust? Vaccine. 2016;34:2424–9. doi:10.1016/j.vaccine.2016.03.087.
45. Attwell K, Freeman M. I Immunise: An evaluation of a values-based campaign to change attitudes and beliefs. Vaccine. 2015;33:6235–40. doi:10.1016/j.vaccine.2015.09.092.
46. Nowak GJ, Gellin BG, MacDonald NE, Butler R,; SAGE Working Group on Vaccine Hesitancy. Addressing vaccine hesitancy: The potential value of commercial and social marketing principles and practices. Vaccine. 2015;33:4204–11. doi:10.1016/j.vaccine.2015.04.039.
47. van der Linden SL, Clarke CE, Maibach EW. Highlighting consensus among medical scientists increases public support for vaccines: evidence from a randomized experiment. BMC Public Health. 2015;15:1207. doi:10.1186/s12889-015-2541-4. PMID:26635296
48. van der Linden S, Leiserowitz A, Rosenthal S, Maibach E. Inoculating the public against misinformation about climate change. Global Challenges. 2017; 1600008. doi: 10.1002/gch2.201600008.
49. Schmidt P, MacDonald NE, Habersaat K, Butler R. Commentary to: How to respond to vocal vaccine deniers in public. Vaccine. 2016;:pii:S0264-410X(16)30914−8 [Epub ahead of print].
50. Thomson A, Watson M. Vaccine hesitancy: A vade mecum v1.0. Vaccine. 2016;34:1989–92. doi:10.1016/j.vaccine.2015.12.049.
51. Ansari MA, Khan Z, Khan IM. Reducing resistance against polio drops. J R Soc Promot Health. 2007;127:276–9.
52. Wheeler M, Buttenheim AM. Parental vaccine concerns, information source, and choice of alternative immunization schedules.Hum Vaccin Immunother. 2013;9:1782–9.
53. Gust DA, Darling N, Kennedy A, Schwartz B. Parents with doubts about vaccines: which vaccines and reasons why. Pediatrics. 2008;122:718–25. doi:10.1542/peds.2007-0538.
54. Fuchs EL., Self-reported prenatal influenza vaccination and early childhood vaccine series completion. Prev Med. 2016;88:8–12. doi:10.1016/j.ypmed.2016.03.012.
55. Healy CM, Montesinos DP, Middleman AB. Parent and provider perspectives on immunization: are providers overestimating parental concerns? Vaccine. 2014;32:579–84. doi:10.1016/j.vaccine.2013.11.076.
56. O'Leary ST, Allison MA, Fisher A, Crane L, Beaty B, Hurley L, Brtnikova M, Jimenez-Zambrano A, Stokley S, Kempe A. Characteristics of Physicians Who Dismiss Families for Refusing Vaccines.Pediatrics. 2015;136:1103–11.
57. Hough-Telford C, Kimberlin DW, Aban I, Hitchcock WP, Almquist J, Kratz R, O'Connor KG. Vaccine Delays, Refusals, and Patient Dismissals: A Survey of Pediatricians. Pediatrics. 2016;138:e20162127. doi:10.1542/peds.2016-2127. PMID:27573091
58. Halperin B, Melnychuk R, Downie J, MacDonald N. When is it permissible to dismiss a family who refuses vaccines? Legal, ethical and public health perspectives. Paediatr Child Health. 2007;12:843–5. doi:10.1093/pch/12.10.843.
59. World Health Organization Regional Office for Europe. Information for parents. If you choose not to vaccinate your child, understand the risks and responsibilities. 2012. Available at: http://www.euro.who.int/__data/assets/pdf_file/0004/160753/If-You-Choose-Not-to-Vaccinate.pdf?ua=1.1 (accessed Jan2017)
60. Opel DJ, Heritage J, Taylor JA, Mangione-Smith R, Salas HS, Devere V, Zhou C, Robinson JD. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132:1037–46. doi:10.1542/peds.2013-2037.
61. Leask J, Kinnersley P, Jackson C, Cheater F, Bedford H, Rowles G. Communicating with parents about vaccination: a framework for health professionals. BMC Pediatr. 2012;12:154. doi:10.1186/1471-2431-12-154. PMID:22998654
62. Gesser-Edelsburg A, Walter N, Shir-Raz Y, Sassoni Bar-Lev O, Rosenblat S. The behind-the-scenes activity of parental decision-making discourse regarding childhood vaccination. Am J Infect Control. 2016;32(2):169–79. pii:S0196-6553(16)30962−2. doi:10.1016/j.ajic.2016.10.009.
63. MacDonald NE, Finlay JC, Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Working with vaccine-hesitant parents. Paediatr Child Health. 2013;18:265–7. doi:10.1093/pch/18.5.265.
64. MacDonald N, Picard A. A plea for clear language on vaccine safety. CMAJ. 2009;180:E2-3:697–8.
65. Yang JZ, Pittman MM. The Silver Lining of Shame: Framing HPV to Influence Vaccination Intentions. Health Commun. 2016:1–8.
66. Sandell T, Sebar B, Harris N. Framing risk: communication messages in the Australian and Swedish print media surrounding the 2009 H1N1 pandemic. Scand J Public Health. 2013;41:860–5. doi:10.1177/1403494813498158.
67. Betch C, Sachse K. Debunking vaccination myths: strong risk negations can increase. Health Psychology. 2013;32:146–55.
68. Hendrix KS, Finnell SM, Zimet GD, Sturm LA, Lane KA, Downs SM. Vaccine message framing and parents' intent to immunize their infants for MMR. Pediatrics. 2014;134:e675−83. doi:10.1542/peds.2013-4077.
69. Broniatowski DA, Hilyard KM, Dredze M. Effective vaccine communication during the Disneyland measles outbreak. Vaccine. 2016;34:3225–8.
70. Taddio A, McMurtry CM, Shah V, Pillai Riddell P, Chambers CT, Noel M, MacDonald NE, Rogers J, Bucci LM and HELPinKids&Adults. Reducing pain during vaccine injections: clinical practice guideline. CMAJ. 2015;187:975–82. doi:10.1503/cmaj.150391.
71. World Health Organization. Reducing pain at the time of vaccination: WHO position paper–September 2015. Weekly Epidemiological Record. 2015;90:505–10.